Does Wegovy cause gastritis, or is it a different kind of stomach upset?

Is gastritis a recognised side effect of Wegovy?

The short answer is no. Gastritis (defined clinically as inflammation of the gastric mucosa) does not appear in the safety profile set out in Wegovy's Summary of Product Characteristics, nor does the NHS medicines page for semaglutide list it among known adverse effects. This does not mean it is impossible for an individual taking semaglutide to develop gastritis from an unrelated cause, but the drug itself has not been shown to trigger it directly.

What Wegovy does reliably produce, for a proportion of users, is a cluster of upper gastrointestinal symptoms: nausea, indigestion, reflux, burping and a generalised sense of fullness or pressure in the abdomen. These arise because semaglutide activates GLP-1 receptors in the gut, slowing the rate at which the stomach empties. When food sits in the stomach longer than usual, the result can feel a lot like gastritis even though the mechanism is quite different.

If you already have a history of gastritis or another inflammatory stomach condition, it is worth raising this during your prescriber assessment. Semaglutide is not automatically ruled out, but your full medical background shapes whether it is the right option for you. Our clinical team discusses exactly these questions before any prescription is issued; you can read more about the clinical oversight approach on the clinical team profile page.

Why do stomach symptoms happen on semaglutide, and when do they peak?

Slowed gastric emptying is the root cause of most GI side effects on Wegovy. When the stomach empties more slowly, gastric acid has longer contact with the stomach wall, and the physical sensation of pressure can build. This produces nausea and, for some people, acid reflux or indigestion, all without any actual inflammation of the lining.

Timing matters here. Symptoms tend to be most noticeable in the first few weeks of treatment and again after each dose increase, because the body needs time to recalibrate. For most people they settle within a couple of weeks. Practical factors help: eating smaller meals, avoiding very fatty or highly processed food, and not lying down straight after eating can all reduce the intensity.

People sometimes ask whether Wegovy causes something broader, like gastroenteritis-type symptoms, vomiting, diarrhoea and stomach cramps together. That profile does occur in some patients, again driven by the GI mechanism, and is distinct from true infectious gastroenteritis. Similarly, many people wonder whether Wegovy can cause gas and bloating, which are reported and tend to respond to the same dietary adjustments, and our page on whether semaglutide causes gas explores why this happens and what you can do about it.

The one symptom that warrants more than a wait-and-see approach is severe stomach pain, particularly pain that persists for hours or spreads to the back. That pattern is a flag for acute pancreatitis, which the MHRA identified in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. Seek urgent medical help if you experience it; do not wait to see if it passes.

Should pre-existing stomach conditions change your decision about Wegovy?

If you have a current diagnosis of gastritis, peptic ulcer disease or another gastric condition, that is a relevant detail for the prescriber assessing your suitability. It does not automatically disqualify you, but the prescriber needs to weigh the potential for worsened discomfort against the clinical benefit for your situation.

People who are already managing reflux or acid-related symptoms sometimes find those symptoms temporarily worsen in the first weeks on Wegovy, then settle. Others find that losing weight (which is associated with reduced intra-abdominal pressure) actually improves long-standing reflux over time. There is no single answer; individual assessment is the only honest response.

For background on what Wegovy is licensed to treat and who typically qualifies, the Wegovy overview page covers the eligibility criteria and the NICE guidance in full. If you are researching where to access Wegovy through a regulated UK provider, the guide to sourcing Wegovy safely covers the supply chain and what to check before placing an order.

When should stomach symptoms on Wegovy prompt you to contact a clinician?

Most GI side effects on semaglutide are uncomfortable rather than dangerous, and they pass. But there are specific patterns that need prompt attention, and it is worth knowing them before you start treatment rather than trying to look them up mid-symptom.

Contact your GP or prescriber if: stomach symptoms are severe rather than merely unpleasant; vomiting is preventing you from keeping fluids down for more than 24 hours; you develop signs of dehydration (dizziness, dark urine, confusion); or you notice pain in the right upper abdomen that could suggest gallbladder involvement. Gallbladder problems, including gallstones, are listed among the less common side effects of semaglutide in clinical data.

Urgent emergency care (not a GP call the next morning) is appropriate for severe, persistent abdominal pain radiating to the back, with or without vomiting, given the pancreatitis risk noted above. You can also report unexpected side effects through the MHRA's Yellow Card scheme, which helps build the ongoing safety picture for medicines like Wegovy.

If you have questions about a symptom you are currently experiencing, our prescribers are available for aftercare seven days a week, or you can reach the team via the contact page. For a broader look at the side-effect profile across different symptoms, the Wegovy side effects overview brings the picture together in one place.